Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

BACKGROUND: Atazanavir (ATV) not boosted by ritonavir (uATV) has been frequently used in the past for switching combination antiretroviral therapy (cART). However, the clinical outcomes and predictors of such strategy are unknown. METHODS: An observational study was carried out on the Italian MASTER...

Descripción completa

Detalles Bibliográficos
Autores principales: Postorino, Maria Concetta, Prosperi, Mattia, Focà, Emanuele, Quiros-Roldan, Eugenia, Di Filippo, Elisa, Maggiolo, Franco, Borghetti, Alberto, Ladisa, Nicoletta, Di Pietro, Massimo, Gori, Andrea, Sighinolfi, Laura, Pan, Angelo, Mazzini, Nicola, Torti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353877/
https://www.ncbi.nlm.nih.gov/pubmed/28298195
http://dx.doi.org/10.1186/s12879-017-2322-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353877/
https://www.ncbi.nlm.nih.gov/pubmed/28298195
http://dx.doi.org/10.1186/s12879-017-2322-z

Ejemplares similares